Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genetic Testing Informed Consent White Paper Will Be Requested By SACGT

This article was originally published in The Gray Sheet

Executive Summary

The HHS Secretary's Advisory Committee on Genetic Testing plans to commission a "white paper" to address variations in informed consent requirements for different types of genetic tests.

You may also be interested in...



Genetic Test Information Template Drafted By SACGT Working Group

A systematic summary of information that will accompany genetic tests for the purpose of premarket review has been drafted by a working group of the HHS Secretary's Advisory Committee on Genetic Testing.

Genetic Test Categorization System Proposed By SACGT Working Group

Predictive genetic tests for disease with no proven intervention available would need heightened scrutiny under a two-tier oversight process proposed at an Aug. 4 meeting of HHS Secretary's Advisory Committee on Genetic Testing in Bethesda, Maryland.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel